Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
See detailLa météorologie et la climatologie dans la politique scientifique belge
Pirot, Pascal ULg

Conference (2013, September 28)

Detailed reference viewed: 36 (5 ULg)
Full Text
Peer Reviewed
See detailMetformin + saxagliptin for type 2 diabetes.
SCHEEN, André ULg

in Expert Opinion on Pharmacotherapy (2012), 13(1), 139-46

INTRODUCTION: Metformin is considered as the first-line drug therapy for the management of type 2 diabetes. Dipeptidyl peptidase-4 (DPP-4) inhibitors, by promoting insulin secretion and reducing glucagon ... [more ▼]

INTRODUCTION: Metformin is considered as the first-line drug therapy for the management of type 2 diabetes. Dipeptidyl peptidase-4 (DPP-4) inhibitors, by promoting insulin secretion and reducing glucagon secretion in a glucose-dependent manner, offer new opportunities for oral therapy after failure of metformin. AREAS COVERED: An updated review of the literature demonstrates that saxagliptin, a DPP-4 inhibitor, and metformin may be administered together, separately or in fixed-dose combination (FDC), either as saxagliptin added to metformin or as initial combination in drug-naive patients. Both compounds exert complementary pharmacodynamic actions leading to better improvement in blood glucose control (fasting plasma glucose, postprandial glucose, HbA1c) than either compound separately. Adding saxagliptin to metformin monthotherapy results in a consistent, sustained and safe reduction in HbA1c levels. Tolerance is excellent without hypoglycemia or weight gain. EXPERT OPINION: The combination saxaglitpin plus metformin may be used as first-line or second-line therapy in the management of type 2 diabetes, especially as a valuable alternative to the classical metformin-sulfonylurea combination. [less ▲]

Detailed reference viewed: 55 (2 ULg)
Full Text
Peer Reviewed
See detailMetformin and lactic acidosis.
SCHEEN, André ULg

in Acta Clinica Belgica (2011), 66(5), 329-31

Detailed reference viewed: 47 (1 ULg)
Full Text
Peer Reviewed
See detailMetformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes.
SCHEEN, André ULg; Paquot, Nicolas ULg

in Diabètes & Métabolism (2013), 39(3), 179-190

Metformin is unanimously considered a first-line glucose-lowering agent. Theoretically, however, it cannot be prescribed in a large proportion of patients with type 2 diabetes because of numerous ... [more ▼]

Metformin is unanimously considered a first-line glucose-lowering agent. Theoretically, however, it cannot be prescribed in a large proportion of patients with type 2 diabetes because of numerous contraindications that could lead to an increased risk of lactic acidosis. Various observational data from real-life have shown that many diabetic patients considered to be at risk still receive metformin and often without appropriate dose adjustment, yet apparently with no harm done and particularly no increased risk of lactic acidosis. More interestingly, recent data have suggested that type 2 diabetes patients considered at risk because of the presence of traditional contraindications may still derive benefit from metformin therapy with reductions in morbidity and mortality compared with other glucose-lowering agents, especially sulphonylureas. The present review analyzes the benefit-risk balance of metformin therapy in special populations, namely, patients with stable coronary artery disease, acute coronary syndrome or myocardial infarction, congestive heart failure, renal impairment or chronic kidney disease, hepatic dysfunction and chronic respiratory insufficiency, all conditions that could in theory increase the risk of lactic acidosis. Special attention is also paid to elderly patients with type 2 diabetes, a population that is growing rapidly, as older patients can accumulate several comorbidities classically considered contraindications to the use of metformin. A review of the recent scientific literature suggests that reassessment of the contraindications of metformin is now urgently needed to prevent physicians from prescribing the most popular glucose-lowering therapy in everyday clinical practice outside of the official recommendations. [less ▲]

Detailed reference viewed: 42 (5 ULg)
Full Text
Peer Reviewed
See detailLa metformine: une molecule antidiabetique dotee de proprietes anti-cancereuses.
BECK, Emmanuel ULg; Scheen, André ULg

in Revue medicale de Liege (2013), 68(9), 444-9

Numerous epidemiological cohort and case-control studies showed that type 2 diabetes is a risk factor for cancer and that metformin therapy is associated with a significant reduction in the incidence of ... [more ▼]

Numerous epidemiological cohort and case-control studies showed that type 2 diabetes is a risk factor for cancer and that metformin therapy is associated with a significant reduction in the incidence of cancer and cancer-related death when compared to other glucose-lowering agents. Such beneficial effect is observed whatever the type of cancer, but seems to be more prominent in case of gastrointestinal and breast cancers. In general, the protective effect was more evident in observational cohort studies (however, more exposed to bias due to confounding factors) than in case-control studies. However, the results of the rather rare controlled clinical trials available are not conclusive, but none of them was performed with the objective to specifically assess cancer risk. Several meta-analyses recently confirmed that metformin therapy reduces the incidence of cancers (including colorectal cancer, hepatocarcinoma, breast cancer) and cancer-related mortality. Metformin may exert its anti-cancer activity by a direct effect (insulin) and an indirect effect (AMPK and mTOR). Considering all promising clinical information in patients with type 2 diabetes, further clinical trials are currently ongoing with the aim of assessing the role of metformin in oncology, especially as adjuvant in breast cancer therapy. [less ▲]

Detailed reference viewed: 102 (3 ULg)
Full Text
See detail(Meth)acrylates pseudo-living radical polymerization in the presence of transition metal complexes: the Kharasch reaction revisited
Granel, Claude; Moineau, George; Lecomte, Philippe ULg et al

in Polymer Preprints (1997), 38(1), 450-451

Detailed reference viewed: 25 (1 ULg)
Full Text
Peer Reviewed
See detailMethacholine bronchoprovocation test:a useful ancillary test for diagnosis of hyperresponsiveness in horses ?
Frippiat, Thibault ULg; Frellstedt, Linda ULg; Bustin, Jean-Clément ULg et al

in Proceedings of the European Veterinary Conference - Voorjaarsdagen (2012)

Detailed reference viewed: 70 (2 ULg)
See detailMéthadone - Détermination du délai entre le prélèvement et la consommation
Dubois, Nathalie ULg

Scientific conference (2009, December)

Detailed reference viewed: 20 (4 ULg)
See detailLa méthadone : une réflexion interdisciplinaire
Cellule Drogues de l'Université de Liège; Gosset, Christiane ULg

Report (1992)

Detailed reference viewed: 45 (10 ULg)
Full Text
Peer Reviewed
See detailMethadone Maintenance Treatment: Is It Possible to Adapt the Daily Doses to the Metabolic Activity of the Patient?
Charlier, Corinne ULg; Dessalles, M. C.; Plomteux, Guy ULg

in Therapeutic Drug Monitoring (2001), 23(1), 1-3

Controversy still exists concerning the proper daily dose of methadone to be used in opiate dependency treatment. Because it is admitted that serum methadone concentration may be significantly correlated ... [more ▼]

Controversy still exists concerning the proper daily dose of methadone to be used in opiate dependency treatment. Because it is admitted that serum methadone concentration may be significantly correlated with the amount of drug available at the receptor level, it could be interesting to predict the methadone daily doses necessary to reach such a serum concentration. The authors have attempted to correlate the serum methadone level with the daily intake, considering the metabolic activity of the patients. A poor correlation was found between methadone doses and methadone serum concentrations (r2 = 0.0409, p = 0.048). The test used to determine the metabolic activity of patients is the 6-OH cortisol/17-OH corticosteroids ratio in urine. This urinary 6-OH cortisol/17-OH corticosteroids ratio was tested because cortisol is metabolized through the same P450 cytochromes as methadone, namely cytochrome P450 3A4. This determination could be of interest because it could be tested before methadone administration to predict optimal doses. But when the authors tried to correlate the methadone serum concentration with the steroid ratio, they failed to find a significant correlation (r2 = 0.0046, N.S.), even when they took into account the daily doses (r2 = 0.0015, N.S.), most probably because of some limitations of the cortisol ratio. [less ▲]

Detailed reference viewed: 26 (6 ULg)
See detailMethane production from the most accessible vegetal wastes of Kinshasa City: mango and cassava leaves
Mambanzulua Ngoma, Philippe ULg; Hiligsmann, Serge; Sumbu Zola, Eric et al

Poster (2013, June)

Leaves of Mangifera Indica (MI, mango leaves) and Manihot Utilissima (MU, cassava leaves) are available in tropical regions and are the most accessible vegetal wastes of Kinshasa, capital of Democratic ... [more ▼]

Leaves of Mangifera Indica (MI, mango leaves) and Manihot Utilissima (MU, cassava leaves) are available in tropical regions and are the most accessible vegetal wastes of Kinshasa, capital of Democratic Republic of Congo. These wastes are not suitably managed and are not rationally valorized. They are abandoned in full air, on the soil and in the rivers. They thus pollute environment. By contrast, they can be recuperated and treated in order to produce methane (energy source), organic fertilizer and clean up the environment simultaneously. The main objective of this study was to investigate methane production from MI and MU leaves by BMP tests at 30 °C. The yields achieved from the anaerobic digestion of up to 61.3 g raw matter in 1 l medium were 0.001 l/g and 0.100 l CH4/g volatile solids of MI and MU leaves respectively. The yield of MU leaves was in the range mentioned in the literature for other leaves because of a poor presence of bioactive substrates, and low C/N ratio. By contrast, the methane yield from MI leaves was almost nil suggesting some metabolism inhibition because of their rich composition in carbon and bioactive substrates. Whereas classical acidogenesis and acetogenesis were recorded. [less ▲]

Detailed reference viewed: 31 (0 ULg)
Full Text
Peer Reviewed
See detailMethane balance of an intensively grazed pasture and estimation of the enteric methane emissions from cattle
Dumortier, Pierre ULg; Aubinet, Marc ULg; Beckers, Yves ULg et al

in Agricultural and Forest Meteorology (2017), 232

The methane turbulent fluxes of an intensively grazed pasture were measured continuously from June 2012 to December 2013 at the Dorinne Terrestrial Observatory (DTO) in Belgium. During grazing periods ... [more ▼]

The methane turbulent fluxes of an intensively grazed pasture were measured continuously from June 2012 to December 2013 at the Dorinne Terrestrial Observatory (DTO) in Belgium. During grazing periods, the fluxes were dominated by enteric fermentation and were found to be strongly related to cow stocking density. In 2013, total emission from the pasture was found between 9 and 11 g CH4 m−2, 97% of which being emitted during grazing periods. Emission per LU (livestock unit) was estimated in a non-invasive way by integrating eddy covariance fluxes over large periods and by assuming a homogeneous average cattle disposition on the pasture. This estimate was compared to the one obtained during confinement periods, where cows were confined in a small part of the pasture. The emission per LU varied between 104 and 134 g CH4 LU−1 day−1 (13 and 17 g CH4 kg DMI−1), depending on the dataset and the computation method used. Diel course was characterized by two emission peaks, one in the morning and a larger one in the afternoon. For rest periods (no cattle on the pasture), small emissions were observed (median and mean values of 0.5 and 1.5 mg CH4 m−2 day−1, respectively). [less ▲]

Detailed reference viewed: 42 (22 ULg)
Full Text
See detailMethane distributions and sea-to-air fluxes in the South China Sea and the West Philippines Sea
Tseng; Chen; Borges, Alberto ULg et al

Poster (2015, July 07)

Detailed reference viewed: 21 (3 ULg)
Full Text
See detailMethane distributions and sea-to-air fluxes in the South China Sea and the West Philippines Sea
Tseng, HC; Chen, C-T A; Borges, Alberto ULg et al

Conference (2015, September 14)

Detailed reference viewed: 15 (1 ULg)